Actieve functies van Jim Pankovich
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Bold Therapeutics, Inc.
 Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018. | Directeur/Bestuurslid | - | - |
| Corporate Officer/Principal | - | - |
Loopbaan van Jim Pankovich
Statistieken
Internationaal
| Canada | 2 |
Operationeel
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Bold Therapeutics, Inc.
Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018. | Health Technology |
- Beurs
- Insiders
- Jim Pankovich
- Ervaring
